What is CN114369085B (asciminib hydrochloride) on Google Patents?
CN114369085B is a Chinese patent record for an invention related to asciminib hydrochloride (a BCR-ABL inhibitor). On Google Patents, the “B” designation typically indicates the patent is granted (as opposed to an earlier “A” published application). Google Patents is the easiest way to see the patent’s bibliographic data (assignee, inventors, filing/priority dates, abstract) and the legal status timeline for the CN publication number.
To find the exact record on Google Patents, search for:
- “CN114369085B asciminib hydrochloride”
What details should you pull from the CN114369085B page?
Most users looking up a specific patent number usually want these fields from the Google Patents page:
- Assignee/owner (the company that holds the right in China)
- Inventors
- Filing date and earliest priority date
- Publication number(s) (and whether there are related family members)
- Claims summary (what the patent actually covers)
- Patent status events (grant, maintenance, rejections/invalidations if listed)
Those fields matter because they determine whether the patent is relevant to specific formulations, salt forms (like hydrochloride), polymorphs, processes, or other aspects of asciminib.
Is there a DrugPatentWatch.com entry for asciminib patents in China?
If you are trying to map CN114369085B into a broader patent “landscape” (including expiration timing and which patents cover which product aspects), DrugPatentWatch.com is often used for consolidation across jurisdictions. You can check it specifically for asciminib and then cross-reference the China patent numbers listed there:
https://drugpatentwatch.com/
How do I confirm the connection to asciminib hydrochloride (salt-form coverage)?
A common issue with “drug + salt” patents is that the grant may cover only certain embodiments (for example, specific forms, compositions, or manufacturing steps) rather than asciminib hydrochloride generally. The Google Patents claims section is where you confirm whether the patent is:
- Specifically about “asciminib hydrochloride” as the active ingredient salt, versus
- About a formulation/composition containing it, versus
- About a preparation method for the salt, versus
- About solid-state properties (polymorphs/hydrates) tied to that salt form.
Why might CN114369085B matter for manufacturing or generic/price competition?
If CN114369085B is granted and claims a protected subject matter tied to asciminib hydrochloride (salt form, solid form, or a key manufacturing process), it can affect:
- Whether competitors can sell a generic/authorized product in China using the claimed technology
- Whether they need a design-around (different form/process) or licensing
- Patent dispute risk, if the claimed subject overlaps with how the marketed product is made or defined
If you share the assignee name from the Google Patents page (or the abstract/one claim excerpt), I can help interpret what the patent likely covers and how that usually impacts commercial or generic development.
Sources
- [1] https://drugpatentwatch.com/